Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
-536K
-
Total reported value, excl. options
-
$29.7M
-
Value change
-
-$1.57M
-
Put/Call ratio
-
0.14
-
Number of buys
-
24
-
Number of sells
-
-21
-
Price
-
$2.75
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2022
60 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2022.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 92.4M outstanding shares and own 11.7% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.04M shares), FMR LLC (1.6M shares), BML Capital Management, LLC (1.11M shares), VANGUARD GROUP INC (1.02M shares), MILLENNIUM MANAGEMENT LLC (205K shares), GEODE CAPITAL MANAGEMENT, LLC (163K shares), RENAISSANCE TECHNOLOGIES LLC (156K shares), Steel Peak Wealth Management LLC (136K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (129K shares), and CONNING INC. (129K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.